Abstract: Purified Bowman-Birk protease inhibitor (BBI) proteins recovered from a soy processing stream are disclosed, as well as a process for recovering and isolating purified BBI proteins from a soy processing stream.

Abstract: A process for recovering and isolating soy whey proteins and other components from whey processing streams is disclosed.

Abstract: The present invention describes novel methods for purifying a BBI product having a total specified BBI protein concentration and other characteristics of BBI (including, for example, chymotrypsin inhibitor activity and endotoxin content).

Abstract: A novel Kunitz-trypsin Inhibitor (KTI) isoform recovered from a processing stream and that has a total KTI protein concentration of at least about 95 wt. % is disclosed, as well as a process for recovering and isolating the purified KTI isoform from a processing stream.

Abstract: The present invention provides protein hydrolysate compositions having enhanced cholecystokinin (CCK) releasing activity that can be used to promote satiety.

Abstract: Methods are provided for the sporulation, sterilization and storage of coccidial oocyst which are characterized by an absence of the highly toxic chemical potassium dichromate. Also provided are compositions containing sporulated oocysts which are free of potassium dichromate.

Abstract: Disclosed are polyol esters comprising a polyol having at least one hydroxyl group esterified to at least one compound having a carboxyl group. Methods of making the polyol ester compounds are also disclosed. The invention also relates to feed compositions comprising polyol ester compounds.

Abstract: An enzymatic synthesis and composition of oligomers and co-oligomers comprised of ?-hydroxy carboxylic acids and ?-amino acids or peptides is disclosed. In a preferred embodiment, a ?-hydroxy carboxylic acid with a specific chiral configuration is linked by an amide linkage to a ?-amino acid specific with a specific chiral configuration or linked by an amide linkage to a peptide made up of ?-amino acid monomers having identical chiral configurations. Proteolytic enzymes catalyze oligomerization of the ?-hydroxy carboxylic acid and ?-amino acid. The degree and distribution of oligomerization varies upon the type and concentrations of different reaction mixtures utilized and upon the length of allowed reaction time. The resultant oligomers may be provided to animals such as ruminants as bioavailable amino acid supplements that are resistant to degradation in the rumen and other animals such as swine, poultry and aquatic animals.

Abstract: Antimicrobial compositions and combinations comprising a compound of Formula I 1

Abstract: Methods are provided for the sporulation, sterilization and storage of coccidial oocyst which are characterized by an absence of the highly toxic chemical potassium dichromate. Also provided are compositions containing sporulated oocysts which are free of potassium dichromate.

Abstract: Methods are provided for determining the digestibility of protein-containing compositions, including food and feed ingredients. The methods comprise incubation of the compositions with proteases, followed by determination of the hydrolyzed peptide bonds. The methods are suitable for rapid, routine determination of digestibility for food and feed processing plants.

Abstract: An enzymatic synthesis and composition of &agr;-hydroxy carboxylic acid and &agr;-amino acid or peptide co-oligomers is disclosed wherein a residue of the &agr;-hydroxy carboxylic acid is linked to a residue of the &agr;-amino acid or peptide by an amide linkage. Proteolytic enzyme papain catalyzes co-oligomerization of the &agr;-hydroxy carboxylic acid and &agr;-amino acid. The degree and distribution of oligomerization varies upon the type and concentrations of different reaction mixtures utilized and upon the length of allowed reaction time. The resultant oligomers may be provided to ruminants as bioavailable amino acid supplements that are resistant to degradation in the rumen.

Abstract: An enzymatic synthesis and composition of &agr;-hydroxy carboxylic acid and &agr;-amino acid or peptide co-oligomers is disclosed wherein a residue of the &agr;-hydroxy carboxylic acid is linked to a residue of the &agr;-amino acid or peptide by an amide linkage. Proteolytic enzyme papain catalyzes co-oligomerization of the &agr;-hydroxy carboxylic acid and &agr;-amino acid. The degree and distribution of oligomerization varies upon the type and concentrations of different reaction mixtures utilized and upon the length of allowed reaction time. The resultant oligomers may be provided to ruminants as bioavailable amino acid supplements that are resistant to degradation in the rumen.

Abstract: An enzymatic synthesis and composition of oligomers and co-oligomers comprised of &agr;-hydroxy carboxylic acids and &agr;-amino acids or peptides is disclosed. In a preferred embodiment, a &agr;-hydroxy carboxylic acid with a specific chiral configuration is linked by an amide linkage to a &agr;-amino acid specific with a specific chiral configuration or linked by an amide linkage to a peptide made up of &agr;-amino acid monomers having identical chiral configurations. Proteolytic enzymes catalyze oligomerization of the &agr;-hydroxy carboxylic acid and &agr;-amino acid. The degree and distribution of oligomerization varies upon the type and concentrations of different reaction mixtures utilized and upon the length of allowed reaction time. The resultant oligomers may be provided to animals such as ruminants as bioavailable amino acid supplements that are resistant to degradation in the rumen and other animals such as swine, poultry and aquatic animals.

Abstract: Methods are provided for the sporulation, sterilization and storage of coccidial oocyst which are characterized by an absence of the highly toxic chemical potassium dichromate. Also provided are compositions containing sporulated oocysts which are free of potassium dichromate.

Abstract: The invention discloses methods and compositions for increasing clot lysis in the presence of exogenous tissue plasminogen activator.

Abstract: The invention discloses a cyclic pentapeptide that inhibits metastasis of malignant cells.

Abstract: Novel peptides which exhibit inhibitory activity toward serine proteases and methods for preparing and using same are disclosed. In one aspect, the present invention provides peptides comprising a generic inhibitory core having a functional site recognition sequence fused to the N-terminus. The functional site recognition sequence is adapted to provide enhanced selectivity and/or potency for a target protease.

Abstract: The invention discloses an acylated pentapeptide that inhibits metastasis activity of malignant cells.

Abstract: Synthetic polypeptides are disclosed which exhibit potent serine protease inhibition. Methods and compositions useful for treating conditions caused by unwanted serine protease activity are also disclosed.